SEC
SlamSEC
SearchBrowseEarnings

IMMUTEP Ltd

Nasdaq:IMMPOTC:PRRUF
Pharmaceutical Preparations·SYDNEY,, C3
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine.